Shortage outlook · all drugs · read October 2026
How long has Rocuronium Bromide been on the FDA shortage list?
Rocuronium Bromide has been on the FDA shortage list for 3 years and 8 months. 87 of the 397 listings measured since 2014 lasted at least that long. Of the 87 past listings that reached the same age, 88% were still listed 6 months later (72 listings measured), 76% were still listed 12 months later (58 listings measured) and 56% were still listed 24 months later (40 listings measured). These are counts of listings, not a forecast.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.
Rocuronium Bromide has been on the FDA shortage list for 3 years and 8 months (March 2023 to October 2026).
- 87 of the 397 listings measured since 2014 lasted at least that long.
- Of the 87 past listings that reached the same age, 88% were still listed 6 months later (72 listings measured), 76% were still listed 12 months later (58 listings measured) and 56% were still listed 24 months later (40 listings measured).
- Rocuronium Bromide has been listed 2 times since 2014: earlier listings lasted 1 year and 8 months.
- None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.
The listing history, to scale
- Rocuronium Bromide InjectionListed April 2017 to September 2018 · 1 year and 8 months
- Rocuronium Bromide InjectionListed since March 2023 · 3 years and 8 months
What past listings of this age did
Of past listings that had already run 3 years and 8 months, how many were still listed later?
What the FDA list says about it today
Reasons companies gave: delay in shipping of the drug (2) and demand increase for the drug (1); 23 of 26 gave none. FDA category: Anesthesia.
Company by company
Of 26 presentations, the companies reported 23 available, 1 with limited availability and 2 unavailable. This is each company's own report to the FDA, with the date of its last update.
- Fresenius Kabi USA, LLC5 presentations · last updated 3 November 2026
- Hospira, Inc., a Pfizer Company4 presentations · last updated 9 November 2026
- Baxter Healthcare2 presentations · last updated 3 November 2026
- Eugia US LLC2 presentations · last updated 19 October 2026
- Hikma Pharmaceuticals USA, Inc.2 presentations · last updated 14 October 2026
- Meitheal Pharmaceuticals, Inc.2 presentations · last updated 27 August 2026
- Mylan Institutional, a Viatris Company2 presentations · last updated 3 November 2026
- Piramal Critical Care Inc.2 presentations · last updated 15 September 2026
- Sandoz Inc.2 presentations · last updated 9 November 2026
- XGen Pharmaceuticals DJB, Inc.2 presentations · last updated 22 September 2026
- Sagent Pharmaceuticals1 presentation · last updated 6 November 2026
FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.
Where can you go from this result?
This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.
- Quinapril Hydrochloride45 months
- Quinapril/Hydrochlorothiazide45 months
- Clindamycin Phosphate43 months
- Clonazepam43 months
To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.